Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/04/03 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 01/11/21 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Samuel Wickline
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/06/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 01/03/18 |
Mats Blom
BRD | Director/Board Member | 59 | 01/04/17 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/04/03 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 2 240 245 | 2 220 245 ( 99,11 %) | 0 | 99,11 % |
Coordinate società
Altamira Therapeutics Ltd.
Clarendon House 2 Church Street
HM 11, Hamilton
+441 295 5950
http://www.altamiratherapeutics.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+16,43% | 122 Mrd | |
+17,36% | 114 Mrd | |
+19,62% | 25,71 Mrd | |
-25,84% | 19,02 Mrd | |
-20,21% | 15,83 Mrd | |
-19,59% | 15,32 Mrd | |
-47,37% | 14,88 Mrd | |
+60,12% | 14,82 Mrd | |
+4,92% | 14,1 Mrd |